<?xml version="1.0"?>
<?xml-stylesheet type="text/css" href="http://www.feuxdelamour.com/v4/skins/common/feed.css?303"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="fr">
		<id>http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=The_most_fundamental_Carfilzomib-Application</id>
		<title>The most fundamental Carfilzomib-Application - Historique des versions</title>
		<link rel="self" type="application/atom+xml" href="http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=The_most_fundamental_Carfilzomib-Application"/>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=The_most_fundamental_Carfilzomib-Application&amp;action=history"/>
		<updated>2026-06-15T18:58:30Z</updated>
		<subtitle>Historique pour cette page sur le wiki</subtitle>
		<generator>MediaWiki 1.20alpha</generator>

	<entry>
		<id>http://www.feuxdelamour.com/v4/index.php?title=The_most_fundamental_Carfilzomib-Application&amp;diff=74972&amp;oldid=prev</id>
		<title>Butane3area : Page créée avec « A total of 1170 patients with TCL [https://en.wikipedia.org/wiki/Cefaloridine Cefaloridine] and 596 control group subjects from 67 cities in Turkey were included in the st... »</title>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=The_most_fundamental_Carfilzomib-Application&amp;diff=74972&amp;oldid=prev"/>
				<updated>2017-03-04T18:09:40Z</updated>
		
		<summary type="html">&lt;p&gt;Page créée avec « A total of 1170 patients with TCL [https://en.wikipedia.org/wiki/Cefaloridine Cefaloridine] and 596 control group subjects from 67 cities in Turkey were included in the st... »&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Nouvelle page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;A total of 1170 patients with TCL [https://en.wikipedia.org/wiki/Cefaloridine Cefaloridine] and 596 control group subjects from 67 cities in Turkey were included in the study. The median age of the TCL subjects was 44.1 years (��?19.2), and 847 (72.4%) of them were female. Examination of at least 1170 control group subjects was planned within the scope of the study. However, only 596 control subjects, 280 (47%) male and 316 (53%) female), were included. The average age of control group subjects was 39.2 years (��?17.1). Significant titres for tularaemia antibody seropositivity were detected in 79 of the patients (6.75%) while two subjects of the control group were found to be positive for significant antibody titres (p?[http://www.selleckchem.com/products/carfilzomib-pr-171.html see more] group when positivities at lower titres were added. The median age of the tularaemia seropositive subjects was 41.2 years (��?19.1) and 50 of them (63.3%) were female. Francisella tularensis-positive antibodies were found in two subjects (0.33%) in the control group with a titre of ��1:80 (p?[http://www.selleckchem.com/products/VX-809.html www.selleckchem.com/products/VX-809.html] lived in rural areas and 37% of the patients were using non-chlorinated water. Among the cases, 60% were feeding cattle in a barn, and 52% had fever and pharyngitis anamnesis (Table?1). According to official records of the years 2005�C2009, the total number of tuberculosis cases varied between 20535 and 17402 annually. Within the same period, while the rate of ETTL was 7.9% (1622 cases) in 2005, it progressively rose and reached a level of 11.7% (2036 cases) in 2009 [14]. Similarly, while the numbers of recorded tularaemia cases were?431 in 2005, this increased to approximately 1500 in 2010. There are only a limited number of case reports indicating that OT was misdiagnosed as TCL [17, 18].&lt;/div&gt;</summary>
		<author><name>Butane3area</name></author>	</entry>

	</feed>